A carregar...
Meropenem–vaborbactam: a new weapon in the war against infections due to resistant Gram-negative bacteria
Meropenem–vaborbactam is a fixed-dose combination product of a carbapenem and a cyclic boronic acid β-lactamase inhibitor with potent in vitro activity against Klebsiella pneumoniae carbapenemase-producing carbapenem-resistant Enterobacteriaceae (CRE). The efficacy of meropenem–vaborbactam for the t...
Na minha lista:
| Publicado no: | Future Microbiol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Future Medicine Ltd
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6161103/ https://ncbi.nlm.nih.gov/pubmed/29692218 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/fmb-2018-0054 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|